Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, reported financial results for the quarter and full year ended December 31, 2022.

On February 20, Roche Group and Zhuhai People's Hospital Medical Group formally signed a strategic cooperation agreement.

Veracyte, Inc. (Nasdaq: VCYT) announced financial results for the fourth quarter and full year ended December 31, 2022.

On February 19, 2023, Abbott, a leading medical and health company in the world, signed a strategic cooperation memorandum with China Medical Devices Co., Ltd., a highly specialized medical device industry chain platform in China, which is affiliated to Sinopharm Holdings.

OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced its financial results for the three months ended December 31, 2022.

Labcorp, a leading global life sciences company, today announced results for the fourth quarter and year ended Dec. 31, 2022, full-year 2023 guidance.

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced financial results for the fourth quarter and full year ended December 31, 2022.

QuidelOrtho Corporation, a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced financial results for the fourth quarter ended January 1, 2023.

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 1, 2023.

Abbott and Cardiovascular Systems, Inc. announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.